Journal Of Clinical Oncology (jco) Podcast
Discussion on the Cost–Effectiveness Analysis of the CALGB/Alliance Trial and the Use of Zoledronic Acid Generic in Women With Metastatic Breast Cancer
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:08:13
- Mas informaciones
Informações:
Sinopsis
The paper examines the cost-effectiveness of schedules of bone-modifying agents in patients with breast cancer and skeletal metastases and supports the 3-month administration of the generic zoledronic acid in terms of cost and efficacy. Read the accompanying article on JCO.org.
